Pharmaceuticals in Marine and Coastal Environments: Occurrence, Effects, and Challenges in a Changing World is divided into three sections that address a) coastal areas as the main entrance of pharmaceuticals into the ocean, b) the occurrence and distribution of pharmaceuticals in the environmental compartments of the ocean media, and c) the effects that such pollutants may cause to the exposed marine organisms. With its comprehensive discussions, the book provides a wide depiction of the current state-of-the-art on these topics in an effort to open new sources of investigation and find suitable solutions.
1. Introduction - p. xxiii 2. Chapter 1. Point and diffuse sources of pharmaceuticals in coastal zones - p. 4 3. Chapter 2. Occurrence, spatiotemporal distribution and environmental fate of pharmaceutical residues in urban estuaries - p. 38 4. Chapter 3. Pharmaceutical active compounds in marine and coastal environments of arid and semi-arid countries of the Arab region - p. 91 5. Chapter 4. Occurrence and distribution of antibiotics and antibiotic resistance determinants in coastal environments - p. 132 6. Chapter 5. Occurrence and environmental fate of pharmaceuticals, personal care products and illicit drugs (PPCPIDs) in tropical ecosystems - p. 169 7. Chapter 6. Environmental risk assessment of pharmaceutical and personal care products in estuarine and coastal waters - p. 200 8. Chapter 7. New sampling methods for detecting pharmaceutical residues in seawater and sediments - p. 253 9. Chapter 8. The present and future challenges in the development of multiresidue analytical methods for the determination of pharmaceuticals in seawater samples - p. 279 10. Chapter 9. Analytical strategies to detect and quantify pharmaceutical residues in marine biota - p. 304 11. Chapter 10. Sources and occurrence of pharmaceutical residues in offshore seawater - p. 331 12. Chapter 11. Occurrence of pharmaceutical residues in marine sediments - p. 351 13. Chapter 12. Pharmaceutical residues in the pristine Antarctic ecosystem - p. 379 14. Chapter 13. On the search of a suitable indicator of pharmaceutical pollution in marine environments - p. 405 15. Chapter 14. Effective biomarkers to assess the toxicity of pharmaceutical residues on marine bivalves - p. 423 16. Chapter 15. Metabolic effects of pharmaceuticals in fish - p. 474 17. Chapter 16. Pharmaceuticals and aquatic benthic organisms: Toxicity and accumulation - p. 501 18. Chapter 17. Endocrine disruption of pharmaceuticals on marine organisms: Thyroidal, gonadotrophic, and behavioral responses - p. 521 19. Chapter 18. Biological effects of antidepressants on marine organisms - p. 568 20. Chapter 19. Impacts of climate change-abiotic factors on the effects caused by pharmaceutical residues to marine organisms - p. 599 21. Chapter 20. Strategies to remove pharmaceutical residues from seawater - p. 625 22. Index - p. 653
Pharmaceuticals in Marine and Coastal Environments: Occurrence, Effects, and Challenges in a Changing World is divided into three sections that address a) coastal areas as the main entrance of pharmaceuticals into the ocean, b) the occurrence and distribution of pharmaceuticals in the environmental compartments of the ocean media, and c) the effects that such pollutants may cause to the exposed marine organisms. With its comprehensive discussions, the book provides a wide depiction of the current state-of-the-art on these topics in an effort to open new sources of investigation and find suitable solutions.
1. Introduction - p. xxiii 2. Chapter 1. Point and diffuse sources of pharmaceuticals in coastal zones - p. 4 3. Chapter 2. Occurrence, spatiotemporal distribution and environmental fate of pharmaceutical residues in urban estuaries - p. 38 4. Chapter 3. Pharmaceutical active compounds in marine and coastal environments of arid and semi-arid countries of the Arab region - p. 91 5. Chapter 4. Occurrence and distribution of antibiotics and antibiotic resistance determinants in coastal environments - p. 132 6. Chapter 5. Occurrence and environmental fate of pharmaceuticals, personal care products and illicit drugs (PPCPIDs) in tropical ecosystems - p. 169 7. Chapter 6. Environmental risk assessment of pharmaceutical and personal care products in estuarine and coastal waters - p. 200 8. Chapter 7. New sampling methods for detecting pharmaceutical residues in seawater and sediments - p. 253 9. Chapter 8. The present and future challenges in the development of multiresidue analytical methods for the determination of pharmaceuticals in seawater samples - p. 279 10. Chapter 9. Analytical strategies to detect and quantify pharmaceutical residues in marine biota - p. 304 11. Chapter 10. Sources and occurrence of pharmaceutical residues in offshore seawater - p. 331 12. Chapter 11. Occurrence of pharmaceutical residues in marine sediments - p. 351 13. Chapter 12. Pharmaceutical residues in the pristine Antarctic ecosystem - p. 379 14. Chapter 13. On the search of a suitable indicator of pharmaceutical pollution in marine environments - p. 405 15. Chapter 14. Effective biomarkers to assess the toxicity of pharmaceutical residues on marine bivalves - p. 423 16. Chapter 15. Metabolic effects of pharmaceuticals in fish - p. 474 17. Chapter 16. Pharmaceuticals and aquatic benthic organisms: Toxicity and accumulation - p. 501 18. Chapter 17. Endocrine disruption of pharmaceuticals on marine organisms: Thyroidal, gonadotrophic, and behavioral responses - p. 521 19. Chapter 18. Biological effects of antidepressants on marine organisms - p. 568 20. Chapter 19. Impacts of climate change-abiotic factors on the effects caused by pharmaceutical residues to marine organisms - p. 599 21. Chapter 20. Strategies to remove pharmaceutical residues from seawater - p. 625 22. Index - p. 653
